About OneCell Diagnostics
OneCell Diagnostics is a Healthcare company based in Cupertino (United States) founded in 2021 by Mohan Uttarwar and Aravindan Vasudevan. It offers genomic testing and AI tools for cancer diagnosis and monitoring. It operates on a B2B and SaaS model. OneCell Diagnostics has raised $16 million across 1 funding round from investors including Cedars Sinai, Tenacity Ventures and Celesta. The company has 33 employees. Its chief executive is Mohan Uttarwar. Its website onecelldx.com draws about 681 thousand monthly visits. Its Indian entity Onecell Diagnostics India Private Limited reported revenue of ₹41.91 Cr. OneCell Diagnostics offers products and services including OncoIndx, OncoDiscover, OncoMonitor, OncoRisk, and iCare. Its focus areas include AI in Medicine, Data Analytics, Cancer Management and Oncology Tech. Its competitors include Denali Therapeutics, Poseida Therapeutics, Castle Biosciences, Juno Therapeutics and Personalis and 4 more; 8 of its 9 listed competitors have raised funding.
Company details
OneCell Diagnostics focuses on precision oncology by developing advanced genomic and AI-based tests for cancer detection and management. They provide services like blood tests for circulating tumor cells and longitudinal monitoring tools. Operating from offices in the United States and India, they serve healthcare providers, patients, and researchers with data analytics platforms to improve treatment decisions and outcomes.
- Headquarters Cupertino, United States
- Employees 33
- Founders Mohan Uttarwar, Aravindan Vasudevan
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website onecelldx.com
- Social LinkedIn Facebook Instagram YouTube
- Legal Name Onecell Diagnostics India Private Limited
- Date of Incorporation 20 Dec, 2021
- Jurisdiction Pune, Maharashtra, India
- Annual Revenue₹41.91 Cr
FY 2025 · +95% YoY
- Net Loss-₹7.60 Cr
FY 2025 · -18% margin
- EBITDA-₹7.20 Cr
FY 2025 · -17% margin
- Total Equity Funding$16M (USD)
in 1 rounds
- Latest Funding Round$16M (USD), Series A
Nov 2024
- InvestorsCedars Sinai
& 4 more
- Employee Count33
Associated legal entities of OneCell Diagnostics
OneCell Diagnostics operates through Onecell Diagnostics India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Onecell Diagnostics India Private Limited CIN U85100PN2021PTC207038 | Active | 20 Dec 2021 | Pune, Maharashtra | ₹41.9 Cr | 33 | 2 | View details |
Products & Services of OneCell Diagnostics
OneCell Diagnostics offers a comprehensive portfolio of products and services, including OncoIndx, OncoDiscover, OncoMonitor, OncoRisk, and iCare.
Comprehensive genomic profiling for detecting cancer alterations and insights.
Detects circulating tumor cells to assess cancer metastasis risks.
Monitors cancer progression through blood-based disease tracking.
Evaluates hereditary cancer risks via gene panel analysis.
AI application for personalized cancer treatment and monitoring.
Tool for analyzing research data in oncology studies.
Apps and channels of OneCell Diagnostics
its YouTube channel 1Cell Ai Inc. has 144 subscribers and 30 videos.
Videos from OneCell Diagnostics
The most watched videos on OneCell Diagnostics's YouTube channel, 1Cell Ai Inc. (144 subscribers). Click a video to play it here.
More on 1Cell Ai Inc..
Funding Insights of OneCell Diagnostics
OneCell Diagnostics has successfully raised a total of $16M through 1 strategic funding round. The most recent funding activity was a Series A round of $16 million completed in November 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $16M
- Total Rounds 1
- Last Round Series A — $16M
- First Round $16M
(Nov 2024)
- Investors Count 5
All 1 funding rounds of OneCell Diagnostics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2024 | $16M | Series A | – | Celesta Capital |
5 investors in total: 5 institutional.
Investors in OneCell Diagnostics
OneCell Diagnostics has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Cedars Sinai, Tenacity Ventures and Celesta.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital firm focused on multiple sectors | – | celesta.vc | San Francisco, United States | |
Technology investment firm focusing on early-growth stages and software businesses in India. | 2021 | tenacity.vc | Mumbai, India | |
- | – | singularityvp.com | - | |
Chain of multispeciality hospital | 1902 | cedars-sinai.org | United States | |
- | – | eragon.tcc.mode | - |
Investor details for OneCell Diagnostics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Onecell Diagnostics India Private Limited (OneCell Diagnostics)
Onecell Diagnostics India Private Limited is the primary company behind OneCell Diagnostics. The board of Onecell Diagnostics India Private Limited currently have 2 directors; the longest-serving is Vijay Prabhakarrao Uttarwar, appointed in 2021. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Vijay Prabhakarrao Uttarwar DIN 00239028 | Director | 20 Dec 2021 | 4 yrs 10 mo | Onecell Diagnostics India Private Limited |
| Rohit Razdan DIN 05138893 | Director | 05 Aug 2025 | 1 yr 2 mo | Onecell Diagnostics India Private Limited |
People of OneCell Diagnostics
11 people are tracked at OneCell Diagnostics (5 in leadership, 6 in team); the tracked headcount is 33.
| Name | Role | Group |
|---|---|---|
Mohan Uttarwar | Co-Founder, CEO | Leadership |
Aravindan Vasudevan | Co-Founder | Leadership |
Sankar Mohan | Senior Director Of Scientific Operations | Leadership |
Surinnder Dang | Chief Business Officer | Leadership |
Jayendra Shinde | General Manager, Data Products | Leadership |
Arshad Ahmed | Business Development And Strategy Advisor | Team |
Pooja T. | Data Analyst | Team |
Sachin Mohanty | Digital Marketing And Creatives Manager | Team |
Bhagwat Jadhav | Research Scientist | Team |
Swathi Nair | Variant Interpretation Scientist | Team |
Madhura Basavalingegowda | Genome Variant Scientist - Reporting Manager | Team |
Complete people profiles for OneCell Diagnostics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of OneCell Diagnostics
Figures of Onecell Diagnostics India Private Limited, the primary company behind OneCell Diagnostics, for FY 2025. Revenue was ₹41.91 Cr (+95% year on year). Net loss was -₹7.60 Cr (-18% margin). EBITDA was -₹7.20 Cr (-17% margin). Revenue has grown at a compounded annual rate of +198% over three years.
- ₹41.91 CrRevenue · FY 2025 · +95% YoY
- -₹7.60 CrNet loss · -18% margin
- -₹7.20 CrEBITDA · -17% margin
- ₹4.6 LakhPaid-up capital
- 33Employees (provident fund records)
- +198%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Onecell Diagnostics India Private Limited are on its company page.
Detailed financial statements for OneCell Diagnostics
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of OneCell Diagnostics
2 dated milestones of OneCell Diagnostics across 3 years, from founding to its latest funding, stage changes and deals.
- Founded OneCell Diagnostics is founded.
- Funding First funding round of $16.0M.
Competitors of OneCell Diagnostics
OneCell Diagnostics has 9 listed competitors in our database, 8 of them funded. They include Denali Therapeutics, Poseida Therapeutics, Castle Biosciences, Juno Therapeutics and Personalis, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| denalitherapeutics.com | 2015 | San Francisco, United States | $347M | 377 | Neurodegenerative disease therapies are developed for Alzheimer's, ALS, and Parkinson's. | |
| poseida.com | 2015 | San Diego, United States | $323.78M | 259 | Developer of gene therapies for treating cancer and liver orphan disease by using gene editing technologies | |
| cernostics.com | 2008 | Pittsburgh, United States | $14.18M | 16 | Precision diagnostic and prognostic tests are developed by Castle Biosciences. | |
| junotherapeutics.com | 2013 | Seattle, United States | $316.67M | 520 | CAR T-cell and T-cell receptor immunotherapies for cancer are developed. | |
| personalis.com | 2011 | Menlo Park, United States | $87.3M | 310 | Genomic sequencing and diagnosis software is provided for healthcare. | |
| unitybiotechnology.com | 2016 | San Francisco, United States | $206M | – | Therapeutics for aging diseases are developed by targeting senescent cells. | |
| unilabs.com | 2000 | Geneva, Switzerland | – | – | Diagnostic services are provided through laboratories and radiology units. | |
| celsiustx.com | 2018 | Cambridge, United States | $148M | 50 | Single-cell RNA and genomic analysis for precision therapeutics are provided. | |
| intelliatx.com | 2014 | Cambridge, United States | $85.02M | 526 | Therapeutics using CRISPR/Cas9 are developed for various diseases. |
Detailed competitors of OneCell Diagnostics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of OneCell Diagnostics
The website of OneCell Diagnostics (onecelldx.com) receives about 680.7K visits a month.
- Monthly visits680.7K
▼ 6.7% vs previous month
Websites whose visitors overlap most with OneCell Diagnostics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| falconebiz.com | 100% | 959.8K | #63,970 | View details | |
| tofler.in | 97% | 556K | #105,509 | View details | |
| zaubacorp.com | 96% | 4.9M | #12,689 | View details | |
| tracxn.com | 92% | 2.9M | #16,597 | View details | |
| indiafilings.com | 90% | 2.1M | #29,959 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for OneCell Diagnostics
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Oncology Informatics
10 companies that operate in the same segment as OneCell Diagnostics (Oncology Informatics), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Cloud applications, data solutions, and information security services are provided. | 2003 | Hopkins, Minnesota, United States | – | – | – | |
Provides AI-driven IT services for healthcare data integration and custom development. | 2015 | Guwahati, Assam, India | – | – | – | |
Provides comprehensive software solutions for clinical analytics. | 2014 | Mumbai, Maharashtra, India | – | USD 521.52 K | 12 | |
Digital intelligence services for the healthcare sector are provided. | 2022 | Shanghai, China | USD 43.05 M | – | – | |
Provides AI, machine learning, and software development for healthcare data insights. | 2008 | Bengaluru, Karnataka, India | – | – | – | |
Delivers health data analytics and content solutions for healthcare organizations. | 2012 | Bengaluru, Karnataka, India | – | USD 334.2 K | 31 | |
Software for ABC and performance management in healthcare is provided. | 1994 | Helsinki, Finland | – | – | – | |
Big data analytics services for clinical trials are provided. | 2021 | – | – | – | – | |
Provides digital platforms for HCP engagement and healthcare marketing solutions. | 2020 | Pune, Maharashtra, India | – | USD 584.35 K | 54 | |
Healthcare data management services are provided for anesthesia practices. | – | – | – | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Onecell Diagnostics
Complete news archive for OneCell Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about OneCell Diagnostics
OneCell Diagnostics was founded in 2021 and raised its 1st funding round 3 years after it was founded.
OneCell Diagnostics is headquartered in Cupertino, United States. It is registered at Cupertino, California, United States.
Mohan Uttarwar is the current CEO of OneCell Diagnostics. They have also founded this company.
OneCell Diagnostics is a funded company, having raised a total of $16M across 1 funding round to date. The company's 1st funding round was a Series A of $16M, raised on Nov 2024.
OneCell Diagnostics has 33 employees.
The primary company behind OneCell Diagnostics, Onecell Diagnostics India Private Limited, reported revenue of ₹41.91 Cr for FY 2025, up 95% year on year.
OneCell Diagnostics focuses on precision oncology by developing advanced genomic and AI-based tests for cancer detection and management. They provide services like blood tests for circulating tumor cells and longitudinal monitoring tools. Operating from offices in the United States and India, they serve healthcare providers, patients, and researchers with data analytics platforms to improve treatment decisions and outcomes.
OneCell Diagnostics's top competitors include Juno Therapeutics, Personalis and Poseida Therapeutics.
OneCell Diagnostics offers OncoIndx, OncoDiscover, OncoMonitor, OncoRisk, and 2 more products and services.
OneCell Diagnostics has 5 investors. Key investors include Cedars Sinai, Tenacity Ventures, Celesta, Eragon, and Singularity Venture Partners.
OneCell Diagnostics operates through Onecell Diagnostics India Private Limited.
The legal entities of OneCell Diagnostics currently have 2 directors, including Vijay Prabhakarrao Uttarwar, Rohit Razdan.